Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

AMINO HEALTHCARE ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1% 1.1%   Bankruptcy risk   5.8% 11.8% 6.2% 5.5% 17.5% 22.7% 16.0% 16.0%   Credit score (0-100)   41 21 38 40 8 3 12 12   Credit rating   BBB BB BBB BBB B B BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 -0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   248 272 332 396 -432 -74.5 0.0 0.0   EBITDA   99.4 14.2 62.4 141 -714 -373 0.0 0.0   EBIT   99.4 14.2 62.4 141 -714 -373 0.0 0.0   Pre-tax profit (PTP)   -60.5 -85.4 61.5 133.3 -715.7 -373.1 0.0 0.0   Net earnings   -47.5 -86.5 26.1 106.8 -715.7 -373.1 0.0 0.0   Pre-tax profit without non-rec. items   -60.5 -85.4 61.5 133 -716 -373 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   416 329 355 462 -254 -627 -716 -716   Interest-bearing liabilities   879 333 290 291 299 265 716 716   Balance sheet total (assets)   1,454 1,163 1,821 1,322 553 273 0.0 0.0   Net Debt   869 331 -443 265 288 144 716 716     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   248 272 332 396 -432 -74.5 0.0 0.0   Gross profit growth   -69.0% 9.8% 22.2% 19.2% 0.0% 82.8% 0.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,454 1,163 1,821 1,322 553 273 0 0   Balance sheet change%   -63.2% -20.0% 56.5% -27.4% -58.2% -50.6% -100.0% 0.0%   Added value   99.4 14.2 62.4 140.9 -713.8 -372.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 -1.0 -2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   40.1% 5.2% 18.8% 35.6% 165.0% 500.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   3.7% 1.1% 4.2% 9.1% -67.1% -43.7% 0.0% 0.0%   ROI %   4.0% 1.5% 9.6% 20.5% -135.6% -132.1% 0.0% 0.0%   ROE %   -10.8% -23.2% 7.6% 26.2% -141.0% -90.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   28.6% 28.3% 19.5% 34.9% -31.5% -69.6% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   873.9% 2,323.4% -709.1% 188.4% -40.3% -38.5% 0.0% 0.0%   Gearing %   211.4% 101.3% 81.7% 63.1% -117.9% -42.3% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   7.8% 16.4% 0.3% 3.5% 0.7% 0.2% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.3 1.4 0.7 0.5 0.5 0.3 0.0 0.0   Current Ratio   1.3 1.4 1.2 1.5 0.7 0.3 0.0 0.0   Cash and cash equivalent   9.9 2.6 732.8 25.9 11.7 121.4 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   327.5 329.0 355.1 461.9 -253.8 -626.9 -357.9 -357.9   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   99 14 62 141 -714 -373 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   99 14 62 141 -714 -373 0 0   EBIT / employee   99 14 62 141 -714 -373 0 0   Net earnings / employee   -47 -87 26 107 -716 -373 0 0